Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated
- 19 October 2021
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 195, 114805
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse
This publication has 60 references indexed in Scilit:
- Molecular Mechanisms of Opioid Receptor-dependent Signaling and BehaviorAnesthesiology, 2011
- Nociceptin/Orphanin FQ Receptor Activation Attenuates Antinociception Induced by Mixed Nociceptin/Orphanin FQ/μ-Opioid Receptor AgonistsThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Statistical power analyses using G*Power 3.1: Tests for correlation and regression analysesBehavior Research Methods, 2009
- Fentanyl Concentrations in 23 Postmortem Cases from the Hennepin County Medical Examiner’s Office*Journal of Forensic Sciences, 2007
- Mechanism-Based Pharmacokinetic-Pharmacodynamic Modelling of the Reversal of Buprenorphine-Induced Respiratory Depression by NaloxoneClinical Pharmacokinetics, 2007
- Anesthetic Potency and Influence of Morphine and Sevoflurane on Respiration in μ-Opioid Receptor Knockout MiceAnesthesiology, 2001
- Clinical Pharmacokinetics of Alfentanil, Fentanyl and SufentanilClinical Pharmacokinetics, 1996
- Evaluation of the morphine reversal actions and antinociceptive activity of a new class of opiate antagonists structurally related to fentanylDrug Development Research, 1991
- New 4-(heteroanilido)piperidines, structurally related to the pure opioidagonist fentanyl, with agonist and/or antagonist propertiesJournal of Medicinal Chemistry, 1989
- Clinical Pharmacokinetics of Fentanyl and its Newer DerivativesClinical Pharmacokinetics, 1983